PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice
about
Akt-ing up on SRPK1: oncogene or tumor suppressor?Intestinal epithelial HuR modulates distinct pathways of proliferation and apoptosis and attenuates small intestinal and colonic tumor developmentPhysiological activation of Akt by PHLPP1 deletion protects against pathological hypertrophyMiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1.High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinomaLoss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis.A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer.SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.PHLPPing through history: a decade in the life of PHLPP phosphatases.Interplay between the phosphatase PHLPP1 and E3 ligase RNF41 stimulates proper kinetochore assembly via the outer-kinetochore protein SGT1.High PHLPP1 expression levels predicts longer time of acquired resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma.PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells.Pleckstrin Homology (PH) Domain Leucine-rich Repeat Protein Phosphatase Controls Cell Polarity by Negatively Regulating the Activity of Atypical Protein Kinase C.Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer.The impact of phosphatases on proliferative and survival signaling in cancer.The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.PHLPP1 is a metastasis suppressor in melanoma
P2860
Q33873895-3584907D-025E-421F-A80A-55CF9C31B02DQ34205259-95DC16ED-093C-4ADC-9599-95B198F3C526Q35003522-5216A7A0-4AB3-45D7-B4B0-62535565F973Q35672735-B31FF078-5F8F-46B5-A77B-C035A2562B9BQ35805551-671C360C-FFB3-4830-A3B8-2FCE0FB8225DQ36011460-B6587A4F-1B68-41B8-8207-FB5E955954EDQ36617953-EFE298AB-BC3B-4766-AC8D-36BC3092ACF6Q36946628-EFF0D2AF-0BB9-42E1-8180-C601C8CBEC0CQ37363464-7DEB4CBE-306B-42D0-B8ED-B0A3341D73F0Q37715728-7CCECA0E-0B62-4751-8C2D-48856483163CQ37745179-23DB9D1B-EBD3-470D-9C85-F894068C13B8Q37746213-F7762370-E8A6-4795-8EFE-09DC6BAC7FB1Q38859044-553F3BBD-8766-468A-AC2A-6E29F9F0F48BQ38962553-A7D239C4-E783-4E92-8CB7-569B22251F59Q39027993-7CE9962E-4A28-4585-8CDF-23273F000380Q41531013-1D0F2C2F-F64D-4C0C-8711-4B52ECFC2D84Q41708722-25D9F1F8-0798-4B40-A24A-DA50A70130D7Q41876633-DF0BD49A-F9E9-47A0-A449-60FECB3DB876Q46874998-7379AE83-C610-42B5-8474-A57B4AA62BCBQ49959094-7FE20688-B167-40CA-B4A0-A779C5CB35E6Q54112403-1277B38A-6B79-46A4-8543-441C0F0386F6Q55024083-2C740519-5C10-4D25-9D9C-B8526FAA1072Q58762298-DD5F0EBD-99E1-4E58-A192-0C67FF447429
P2860
PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PHLPP is a negative regulator ...... ents tumor progression in mice
@ast
PHLPP is a negative regulator ...... ents tumor progression in mice
@en
PHLPP is a negative regulator ...... ents tumor progression in mice
@en-gb
PHLPP is a negative regulator ...... ents tumor progression in mice
@nl
type
label
PHLPP is a negative regulator ...... ents tumor progression in mice
@ast
PHLPP is a negative regulator ...... ents tumor progression in mice
@en
PHLPP is a negative regulator ...... ents tumor progression in mice
@en-gb
PHLPP is a negative regulator ...... ents tumor progression in mice
@nl
prefLabel
PHLPP is a negative regulator ...... ents tumor progression in mice
@ast
PHLPP is a negative regulator ...... ents tumor progression in mice
@en
PHLPP is a negative regulator ...... ents tumor progression in mice
@en-gb
PHLPP is a negative regulator ...... ents tumor progression in mice
@nl
P2093
P2860
P921
P3181
P1433
P1476
PHLPP is a negative regulator ...... ents tumor progression in mice
@en
P2093
Haihua Yang
Jianyu Liu
Micheal D Schmidt
Payton D Stevens
Tianyan Gao
P2860
P304
1301-12.e1-10
P3181
P356
10.1053/J.GASTRO.2014.02.003
P407
P577
2014-05-01T00:00:00Z